TAK-075

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameTAK-075
Drug Alias NameTAK-075
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcium sensing receptor antagonists
TargetsCalcium sensing receptor
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A